Feature | EP Mapping and Imaging Systems | September 17, 2015

MedLumics Technology Validated for Real-time Catheter Ablation Assessment in Atrial Fibrillation

Optical coherence tomography technology may help improve clinical outcomes through direct information on ablation efficacy

MedLumics, OCT, real-time assessment, catheter ablation, atrial fibrillation

September 17, 2015 — MedLumics has announced the completion of a successful single-case pre-clinical feasibility study of its optical coherence tomography (OCT) technology in the catheter ablation treatment of atrial fibrillation (AF). The study incorporated a novel catheter capable of simultaneous radiofrequency ablation and imaging based on MedLumics’ polarization-sensitive optical coherence reflectometry. This showed that the combined technology may help improve clinical outcomes by providing direct, real-time information on ablation efficacy.  Results of the study were published in the August issue of The Journal of Innovations in Cardiac Rhythm Management.

Many technologies have emerged over the last several years to advance the catheter ablation treatment of AF, yet the procedure remains highly complex and unpredictable.  Recurrence rates at one-year follow-up exceed approximately 60 percent in broad registries. A widely accepted cause of recurrence after initially successful treatment is pulmonary vein reconnection due to ineffective lesion formation.

MedLumics’ imaging technology is designed to provide clinicians with direct, real-time information on lesion formation in the tissue surrounding the catheter’s radiofrequency electrode. In addition to capturing the distance and contact quality between cardiac tissue and catheter tip, it uniquely allows clinicians to analyze changes in tissue optical properties during the ablation procedure. This added information may offer clinicians a new and direct method for evaluating lesion efficacy during catheter ablation procedures, thereby improving treatment effectiveness and reducing recurrence rates. The company is currently developing a clinical version of the catheter with full 360-degree coverage of the tissue around the catheter tip and state-of-the art irrigation.

The new cardiac application of MedLumics’ technology builds on its current product in dermatology. In 2014, the company debuted its NITID skin imaging system. Recently approved by regulatory bodies in Europe and now being commercialized by the company’s spinout DermaLumics, it is the first point-of-care OCT imaging device that can produce dynamic, real-time, high-resolution diagnostic images with tissue penetration capability of up to two millimeters.

For more information: www.medlumics.com

Related Content

Feature | EP Lab | January 21, 2019 | Matthew S. McKillop, M.D., FACC, FHRS, and Seth J. Worley, M.D.
Interventional...
An implanted ICD showing its three venous leads. These multiple CRT leads can cause issues when they need to be replaced and are abandoned with new leads put over them in the SVC, which may require lead extraction.

An implanted ICD showing its three leads in the venous system. 

Feature | EP Lab | January 13, 2019 | Dave Fornell, Editor
To extract or abandon broken or infected implantable, venous...
Videos | EP Lab | January 03, 2019
This is a quick video tour of one of the dedicated...
HHS and NASA Team Up to Explore Health on Earth and in Outer Space

Image courtesy of NASA

News | EP Lab | December 14, 2018
The Department of Health and Human Services (HHS) recently entered into an interagency agreement with the National...
Technology Improvements Driving Electrophysiology Market Growth

Navik 3D Cardiac Mapping System image courtesy of APN Health.

News | EP Lab | December 10, 2018
December 10, 2018 — Electrophysiology, whil
Vagal Maneuvers With Supraventricular Tachycardia

Image courtesy of ACLS Certification Institute

Feature | EP Lab | December 05, 2018
Supraventricular tachycardia (SVT) is a common heart abnormality that presents as a fast heart rate. SVT is a generic...
Societies Publish New Guidance for Treatment of Slow, Irregular Heartbeats
News | EP Lab | November 09, 2018
The American College of Cardiology (ACC), the American Heart Association (AHA) and the Heart Rhythm Society (HRS)...
A view of the EPD Solutions catheter ablation system image guidance. It displays the catheter within a pre-acquired 3D segmented CT image. The D700 system provides a real-time lesion assessment tool that predicts transmurality and permanency of lesions, pre- and immediately post-ablation.

A view of the EPD Solutions catheter ablation system image guidance. It displays the catheter within a pre-acquired 3D segmented CT image. The D700 system provides a real-time lesion assessment tool that predicts transmurality and permanency of lesions, pre- and immediately post-ablation.

News | EP Lab | June 05, 2018
June 5, 2018 — Philips Healthcare has signed an agreement to acquire EPD Solutions, a provider of image-guidance in c
A recent study shows the Baylis NRG radiofrequency (RF) Transseptal puncture catheter has a lower incidence of embolism in EP cases.
News | EP Lab | May 21, 2018
May 21, 2018 — A recent study published in Heart and Vessels has found that the use of the Baylis Medical NR
Overlay Init